4.6 Article

Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium

期刊

MODERN PATHOLOGY
卷 27, 期 3, 页码 472-491

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/modpathol.2013.80

关键词

hepatoblastoma; pathology; pediatric liver cancer classification; prognosis

资金

  1. Children's Oncology Group Liver Tumors Committee
  2. European FP7 European Network for Cancer Research in Children and Adolescents [261474]
  3. Rare Tumors Committee
  4. Grants-in-Aid for Scientific Research [25670743, 25293359, 23256006, 26670764] Funding Source: KAKEN

向作者/读者索取更多资源

Liver tumors are rare in children, and their diagnoses may be challenging particularly because of the lack of a current consensus classification system. Systematic central histopathological review of these tumors performed as part of the pediatric collaborative therapeutic protocols has allowed the identification of histologic subtypes with distinct clinical associations. As a result, histopathology has been incorporated within the Children's Oncology Group (COG) protocols, and only in the United States, as a risk-stratification parameter and for patient management. Therefore, the COG Liver Tumor Committee sponsored an International Pathology Symposium in March 2011 to discuss the histopathology and classification of pediatric liver tumors, and hepatoblastoma in particular, and work towards an International Pediatric Liver Tumors Consensus Classification that would be required for international collaborative projects. Twenty-two pathologists and experts in pediatric liver tumors, including those serving as central reviewers for the COG, European Societe Internationale d'Oncologie Pediatrique, Gesellschaft fur Padiatrische Onkologie und Hamatologie, and Japanese Study Group for Pediatric Liver Tumors protocols, as well as pediatric oncologists and surgeons specialized in this field, reviewed more than 50 pediatric liver tumor cases and discussed classic and newly reported entities, as well as criteria for their classification. This symposium represented the first collaborative step to develop a classification that may lead to a common treatment-stratification system incorporating tumor histopathology. A standardized, clinically meaningful classification will also be necessary to allow the integration of new biological parameters and to move towards clinical algorithms based on patient characteristics and tumor genetics, which should improve future patient management and outcome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据